Clinical Trials Browser

Phase 1 × Withdrawn × glucose-regulated proteins × Clear all

NCT01799161 2014-11-17

Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms